From: An integrated pharmacokinetics ontology and corpus for text mining
DDI relationship | C1 | C2 | C3** | C4** |
---|---|---|---|---|
IN VIVO STUDY | ||||
DDI | Yes | Yes | The PK parameter with the highest priority* must satisfy p-value <0.05 and FC > 1.50 or FC < 0.67 | Significant, obviously, markedly, greatly, pronouncedly and etc. |
Ambiguous DDI (ADDI) | The PK parameter with the highest priority* in the conditions of p-value <0.05 but 0.67 < FC < 1.50; or FC >1.50 or FC <0.67, but p-value > 0.05. | Modestly, moderately, probably, may, might, and etc. | ||
Non-DDI (NDDI) | The PK parameter with the highest priority*are in the condition of p-value > 0.05 and 0.67 < FC < 1.50 | Minor significance, slightly, little or negligible effect, doesn’t interact etc. | ||
IN VITRO STUDY | ||||
DDI | Yes | Yes | (0< Ki < 10 or 0< EC50 < 10 microM, and p-value <0.05) | Significant, obviously, markedly, greatly, pronouncedly and etc. |
DEI | ||||
Ambiguous DDI (ADDI) | (10 < Ki < 100 or 10 < EC50 < 100 microM, and p-value <0.05 or vice versa) | Modestly, moderately, probably, may, might, and etc. | ||
Ambiguous DEI (ADEI) | ||||
Non-DDI (NDDI) | (Ki > 100 microM or EC50 > 100 microM, and p-value >0.05) | Minor significance, slightly, little or negligible effect, doesn’t interact etc. | ||
Non-DEI (NDEI) | Â | Â | Â | Â |